Wells Fargo’s Aethlon Medical AEMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1
Closed -$2 – 7321
2026
Q2
$2 Hold
1
– – ﹤0.01% 7209
2026
Q1
$6 Hold
1
– – ﹤0.01% 7004
2025
Q4
$7 Hold
1
– – ﹤0.01% 6920
2025
Q3
$19 Hold
1
– – ﹤0.01% 6709
2025
Q2
$31 Hold
1
– – ﹤0.01% 6674
2025
Q1
$76 Hold
1
– – ﹤0.01% 6399
2024
Q4
$181 Hold
1
– – ﹤0.01% 6371
2024
Q3
$98 Hold
1
– – ﹤0.01% 6281
2024
Q2
$105 Hold
1
– – ﹤0.01% 6247
2024
Q1
$386 Hold
1
– – ﹤0.01% 6337
2023
Q4
$504 Hold
1
– – ﹤0.01% 6378
2023
Q3
$519 Hold
1
– – ﹤0.01% 6356
2023
Q2
$821 Hold
1
– – ﹤0.01% 6372
2023
Q1
$871 Hold
1
– – ﹤0.01% 6419
2022
Q4
$626 Hold
1
– – ﹤0.01% 6323
2022
Q3
$1K Hold
1
– – ﹤0.01% 6255
2022
Q2
$2K Hold
1
– – ﹤0.01% 6282
2022
Q1
$3K Hold
1
– – ﹤0.01% 6564
2021
Q4
$4K Hold
1
– – ﹤0.01% 6733
2021
Q3
$8K Hold
1
– – ﹤0.01% 6262
2021
Q2
$10K Hold
1
– – ﹤0.01% 6132
2021
Q1
$4K Hold
1
– – ﹤0.01% 6528
2020
Q4
$5K Hold
1
– – ﹤0.01% 6131
2020
Q3
$3K Hold
1
– – ﹤0.01% 6070
2020
Q2
$4K Hold
1
– – ﹤0.01% 5997
2020
Q1
$3K Hold
1
– – ﹤0.01% 5920
2019
Q4
$2K Buy
+1
New +$12K ﹤0.01% 6149

Other funds holding AEMD

Wells Fargo's AEMD Position: Q3 2026 in Review

Wells Fargo sold out of Aethlon Medical (AEMD) in Q3 2026, closing a stake of 1 share — an estimated $2 sold.

Wells Fargo first reported a position in AEMD in Q4 2019 and held it in 27 quarters. The position peaked at $10K in Q2 2021. 17 funds tracked by Wall St. Rank hold AEMD as of Q3 2026.

  • Wells Fargo reported no remaining Aethlon Medical position as of Q3 2026 after selling out during the quarter.
  • Wells Fargo sold 1 Aethlon Medical share in Q3 2026, an estimated $2.
  • Wells Fargo first reported a position in Aethlon Medical in Q4 2019 and held it in 27 quarters.
  • Wells Fargo's Aethlon Medical position peaked at $10K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Aethlon Medical as of Q3 2026.

Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.